29 completed, 6 terminated, 3 recruiting, 2 unknown. 43 Phase 2, 9 Phase 1, 4 Phase 3.
Follow Medication Adherence: new trials by email Literature Review of Medication Adherence trials Research Report on Medication Adherence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation Varenicline (VAR), Nicotine lozenge (NRT), Smartphone intervention with adherence components (COMBO-A) - Smoking Cessation | Phase 2 | Recruiting | University of Oklahoma | 496 | 2026-07-21 | 2026-11-09 |
| An Integrated Intervention Using a Pill Ingestible Sensor System ISS-SBDOH arm - HIV/AIDS, Medication Adherence | Phase 2 | Recruiting | University of California, Los Angeles | 110 | 2024-12-19 | 2026-02-13 |
| Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial Cognitive Training - Mild Cognitive Impairment (MCI), Cognitive Training | Phase 2 | Recruiting | Columbia University | 240 | 2024-12-17 | 2026-07-28 |
| Preventing Medication Mismanagement in People Living With Dementia Through Automated Medication Dispensing With Facial Recognition and Video Observation HiDO-ALZ - Alzheimer Disease, Dementia | Phase 2 | Completed | HiDO Technologies | 50 | 2024-09-05 | 2026-10-07 |
| Heart Failure Polypill at a Safety Net Hospital Heart failure polypill, Control Rx - Heart Failure With Reduced Ejection Fraction, HIV Infections | Phase 2 | Completed | University of California, San Francisco | 35 | 2024-02-27 | 2025-12-31 |
| Project Engage: Oral PrEP Acceptability emtricitabine/tenofovir alafenamide, Emtricitabine / Tenofovir Disoproxil Oral Tablet - Acceptability of Health Care, Adherence, Medication | Phase 2 | Completed | Eastern Virginia Medical School | 330 | 2022-06-21 | 2024-07-29 |
| Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers Maintenance ICS and Symptom Driven SABA, Symptom-driven budesonide/formoterol combination - Asthma in Children, Nonadherence, Medication | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 55 | 2022-04-01 | 2026-08-19 |
| Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA - Asthma, Nonadherence, Medication | Phase 1 / Phase 2 | Active not recruiting | Washington University School of Medicine | 60 | 2021-12-16 | 2026-08-19 |
| Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors Motivational enhancement therapy, Attention Control - Breast Cancer, Medication Adherence | Phase 2 / Phase 3 | Withdrawn | University of Calgary | 2020-08-01 | 2024-12-05 | |
| Alterations in the Vaginal Microenvironment Using a Non-pharmacological Intervention Vaginal Renewal Program - Adherence, Medication | Phase 2 | Terminated | University of Wisconsin, Madison | 2 | 2019-11-19 | 2021-10-20 |
| Medication Responsiveness in Parkinson's Disease CloudUPDRS - Tapping Task - Parkinson Disease, Medication Compliance | Phase 2 | Completed | KU Leuven | 33 | 2019-07-25 | 2021-01-27 |
| Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment Polycap - Atherosclerosis, Adherence, Medication | Phase 2 | Completed | Northern California Institute of Research and Education | 148 | 2019-02-14 | 2023-12-20 |
| Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C] Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a - Hepatitis C, Chronic | Phase 2 / Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 150 | 2018-02-02 | 2021-05-18 |
| Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers Nicotine Patch, Questionnaires, Carbon Monoxide (CO) Test - Tobacco Use Cessation, Cancer Prevention | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 26 | 2015-11-02 | 2020-03-10 |
| Emtricitabine/Tenofovir Alafenamide as Salvage ART FTC/TAF - HIV | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 1 | 2015-09-16 | 2017-11-14 |
| Directly Observed Therapy for HCV in Chennai, India Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin - Hepatitis C, Chronic | Phase 2 | Completed | Johns Hopkins Bloomberg School of Public Health | 50 | 2015-09-01 | 2021-04-15 |
| Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication. Experimental - Medication Adherence | Phase 2 | Completed | Inflexxion, Inc. | 176 | 2012-09-01 | 2014-05-19 |
| Nurse Delivered Cell Phone Adherence Intervention (Pick It UP) Adherence Counseling, General Health Counseling, Text Messages - Medication Adherence | Phase 1 / Phase 2 | Completed | University of Connecticut | 600 | 2011-07-01 | 2014-12-03 |
| Adaptive Goal-Directed Adherence Tracking and Enhancement AGATE, SASED - Alcohol Abuse | Phase 2 | Completed | Talaria, Inc | 136 | 2011-07-01 | 2014-05-13 |
| Holistic Approaches to Depression Yoga, Healthy Living Workshop - Depression | Phase 2 | Completed | Butler Hospital | 121 | 2011-06-01 | 2016-04-13 |
Showing 20 of 43. Sign in to see all of them.
Health Education (14) · Directly Observed Therapy (7) · HIV Infections (6) · Acquired Immunodeficiency Syndrome (4) · Asthma (3) · Alcoholism (2) · Atherosclerosis (2) · Depression (2) · Diabetes Mellitus, Type 2 (2) · Hepatitis C, Chronic (2) · Low Back Pain (2) · Motor Activity (2) · Smoking Cessation (2) · Adherence Interventions (1)
Health Behavior (43) · Patient Compliance (43) · Treatment Adherence and Compliance (43) · Behavior (42) · Patient Acceptance of Health Care (42) · Adherence Interventions (14) · Immune System Diseases (12) · Blood-Borne Infections (10) · Communicable Diseases (10) · Infections (10) · RNA Virus Infections (10) · Virus Diseases (10) · Urogenital Diseases (9) · Genital Diseases (8)
Emtricitabine (2) · Exercise (2) · Sofosbuvir (2) · Tobacco Use Cessation Devices (2) · peginterferon alfa-2a (2) · Carbon Monoxide (1) · Cognitive Training (1) · Counseling (1) · Diet Therapy (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Fluoxetine (1) · Formoterol Fumarate (1) · Lopinavir (1) · Meditation (1) · Mindfulness-Based Stress Reduction (1)
Butler Hospital (2) · Johns Hopkins Bloomberg School of Public Health (2) · Kovacs Foundation (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · San Diego State University (2) · University of California, San Francisco (2) · Washington University School of Medicine (2) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · Brigham and Women's Hospital (1) · Centers for Disease Control and Prevention (1) · Children's Mercy Hospital Kansas City (1) · Columbia University (1) · Eastern Virginia Medical School (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Georgetown University (1)
United States (30) · South Africa (3) · Canada (2) · India (2) · Spain (2) · Belgium (1) · France (1) · Ghana (1) · Pakistan (1) · Puerto Rico (1) · Zimbabwe (1)
Christina D Adams, PhD (2) · Alexander Dromerick, MD (1) · Alice Nieuwboer (1) · Alice Pau, Pharm.D. (1) · Ana Abrantes, PhD (1) · Antonio Ruiz, MD (1) · Ashley J Beard, PhD (1) · Carlos Isanta, MD (1) · Celia Albaladejo, MD (1) · Charles Flexner, MD (1) · Chelsea S. Kidwell, MD (1) · Colette DeJong, MD (1) · Connie M Trinacty, PhD (1) · Darla E. Kendzor, Ph.D. (1)
PMID 11764222, PMID 11852377, PMID 12037511, PMID 12448827, PMID 12746623, PMID 12846028, PMID 19255065, PMID 19597072, PMID 19928484, PMID 20147875, PMID 20192725, PMID 20453627, PMID 23186301, PMID 23248342, PMID 25909320, PMID 27347650, PMID 27590273, PMID 28719029, PMID 29540234, PMID 30633744, PMID 31141465, PMID 36471430, PMID 37268772, PMID 37734804, PMID 39082406, PMID 40118491, PMID 40852373, PMID 41174603
KL2TR002346 (2), R01DA026727 (2), UL1TR002345 (2), K01CA160670 (1), K23DA019950 (1), P60AR036308 (1), R01AA018923 (1), R01AG052440 (1), R01AI055359 (1), R01AR044020 (1), R01CA298165 (1), R01MD019188 (1), R01MH063011 (1), R01NR012005 (1), R01NR012962 (1)